Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
F Schifano, A Vento, N Scherbaum & A Guirguis. (2023) Stimulant and hallucinogenic novel psychoactive substances; an update. Expert Review of Clinical Pharmacology 16:11, pages 1109-1123.
Read now
Read now
Russ Scott. (2023) Methamphetamine dependence in Australia–why is ‘ice’ (crystal meth) so addictive?. Psychiatry, Psychology and Law 0:0, pages 1-34.
Read now
Read now
Articles from other publishers (36)
Rasmon Kalayasiri, Kanokwan Dadwat, Supaksorn Thika, Sunee Sirivichayakul & Michael Maes. (2023) Methamphetamine (MA) use and MA-induced psychosis are associated with increasing aberrations in the compensatory immunoregulatory system, interleukin-1α, and CCL5 levels. Translational Psychiatry 13:1.
Crossref
Crossref
Othalefile E. Otlhapile, Catherine W. Gitau & Mary W. Kuria. (2023) The prevalence of substance use disorders and associated characteristics among patients admitted to a psychiatric hospital in Botswana. The International Journal of Psychiatry in Medicine 58:4, pages 339-357.
Crossref
Crossref
Rebecca McKetin, Philip J. Clare, David Castle, Alyna Turner, Peter J. Kelly, Dan I. Lubman, Shalini Arunogiri, Victoria Manning & Michael Berk. (2023) How does a family history of psychosis influence the risk of methamphetamine‐related psychotic symptoms: Evidence from longitudinal panel data. Addiction.
Crossref
Crossref
Sophie C. Morse, Callan Fockele, Ly Ngoc Huynh, Alina Zatzick & Lauren Kirsten Whiteside. (2023) A qualitative study of people who use methamphetamine during the early COVID-19 pandemic to inform future ED harm reduction strategies. International Journal of Emergency Medicine 16:1.
Crossref
Crossref
Els F. Halff, Grazia Rutigliano, Anna Garcia-Hidalgo & Oliver D. Howes. (2023) Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders. Trends in Neurosciences 46:1, pages 60-74.
Crossref
Crossref
Ernest T. Chivero, Susmita Sil, Mohit Kumar & Shilpa Buch. (2022) Substance use, microbiome and psychiatric disorders. Pharmacology Biochemistry and Behavior 219, pages 173432.
Crossref
Crossref
Simon Digé & Julia Bodin. (2022) Symptômes psychotiques et psychostimulants. Annales Médico-psychologiques, revue psychiatrique.
Crossref
Crossref
Joseph M. Barnby, Mitul A. Mehta & Michael Moutoussis. (2022) The computational relationship between reinforcement learning, social inference, and paranoia. PLOS Computational Biology 18:7, pages e1010326.
Crossref
Crossref
Tong Ni, Li Zhu, Shuai Wang, Weili Zhu, Yanxue Xue, Yingjie Zhu, Dongliang Ma, Hongyan Wang, Fanglin Guan & Teng Chen. (2022) Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABAB1 receptor expression. Molecular Psychiatry.
Crossref
Crossref
Christopher M. Jones, Debra Houry, Beth Han, Grant Baldwin, Alana Vivolo‐Kantor & Wilson M. Compton. (2021) Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction. Annals of the New York Academy of Sciences 1508:1, pages 3-22.
Crossref
Crossref
Kristina M. Gicas, Puneet K. Parmar, Giulia F. Fabiano & Farzaneh Mashhadi. (2022) Substance-induced psychosis and cognitive functioning: A systematic review. Psychiatry Research 308, pages 114361.
Crossref
Crossref
Craig Cumming, Gregory Armstrong, Rohan Borschmann, James A Foulds, Giles Newton-Howes, Rebecca McKetin, Shannen Vallesi, David Preen & Jesse Young. (2022) Amphetamine-type stimulant use and self-harm: protocol for a systematic review of observational studies. BMJ Open 12:1, pages e057029.
Crossref
Crossref
Xiaojian Jia, Jianhong Wang, Wentao Jiang, Zhi Kong, Huan Deng, Wentao Lai, Caihong Ye, Fen Guan, Peng Li, Min Zhao & Mei Yang. (2022) Common gray matter loss in the frontal cortex in patients with methamphetamine-associated psychosis and schizophrenia. NeuroImage: Clinical 36, pages 103259.
Crossref
Crossref
Markus Karl Huber, Josef Schwitzer, Erwin Kirchler & Peter Lepping. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
955
974
.
Alessio Fiorentini, Filippo Cantù, Camilla Crisanti, Guido Cereda, Lucio Oldani & Paolo Brambilla. (2021) Substance-Induced Psychoses: An Updated Literature Review. Frontiers in Psychiatry 12.
Crossref
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
451
536
.
Edward Millgate, Eugenia Kravariti, Alice Egerton, Oliver D Howes, Robin M Murray, Laura Kassoumeri, Jacek Donocik, Shôn Lewis, Richard Drake, Stephen Lawrie, Anna Murphy, Tracy Collier, Jane Lees, Charlotte Stockton-Powdrell, James Walters, Bill Deakin & James MacCabe. (2021) Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study. BMJ Open 11:11, pages e054160.
Crossref
Crossref
Mei Yang, Xiaojian Jia, Hongying Zhou, Ping Ren, Huan Deng, Zhi Kong, Chunyu Xie, Wenjun Hu, Wentao Jiang, Wentao Lai, Bin Zhang, Min Zhao & Tiebang Liu. (2021) Brain dysfunction of methamphetamine‐associated psychosis in resting state: Approaching schizophrenia and critical role of right superior temporal deficit. Addiction Biology 26:6.
Crossref
Crossref
Dayle Raftery, Peter J. Kelly, Frank P. Deane, Gregory Carter, Olivia M. Dean, Dan I. Lubman, Alyna Turner & Rebecca McKetin. (2021) Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use. Journal of Substance Abuse Treatment 130, pages 108473.
Crossref
Crossref
Rebecca McKetin, Olivia M. Dean, Alyna Turner, Peter J. Kelly, Brendan Quinn, Dan I. Lubman, Paul Dietze, Gregory Carter, Peter Higgs, Barbara Sinclair, David Reid, Amanda L. Baker, Victoria Manning, Nina te Pas, Tamsin Thomas, Ramez Bathish, Dayle K. Raftery, Anna Wrobel, Lucy Saunders, Shalini Arunogiri, Frank Cordaro, Harry Hill, Scott Hall, Philip J. Clare, Mohammadreza Mohebbi & Michael Berk. (2021) N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial. eClinicalMedicine 38, pages 101005.
Crossref
Crossref
Shichao Tang, Christopher M. Jones, April Wisdom, Hsien-Chang Lin, Sarah Bacon & Debra Houry. (2021) Adverse childhood experiences and stimulant use disorders among adults in the United States. Psychiatry Research 299, pages 113870.
Crossref
Crossref
Alexandra Voce, Richard Burns, David Castle, Bianca Calabria & Rebecca McKetin. (2021) A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use. Psychiatry Research 298, pages 113760.
Crossref
Crossref
Zhuo Wang, Chen Li, Jiuyang Ding, Yanning Li, Zhihua Zhou, Yanjun Huang, Xiaohan Wang, Haoliang Fan, Jian Huang, Yitong He, Jianwei Li, Jun Chen & Pingming Qiu. (2021) Basolateral Amygdala Serotonin 2C Receptor Regulates Emotional Disorder-Related Symptoms Induced by Chronic Methamphetamine Administration. Frontiers in Pharmacology 12.
Crossref
Crossref
Nevriye A. YesilNevriye A. Yesil. 2021. Drogen haben kurze Beine. Drogen haben kurze Beine
71
103
.
Markus Karl Huber, Josef Schwitzer, Erwin Kirchler & Peter Lepping. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
20
.
Laurent Michel, Linh T. Nguyen, An K. Nguyen, John P. Ekwaru, Didier Laureillard, Nicolas Nagot, Olivier Phan & Oanh T. H. Khuat. (2020) Exposure to HIV risks among young people who use drugs (YPUD) in three cities in Vietnam: time to develop targeted interventions. Harm Reduction Journal 17:1.
Crossref
Crossref
Joseph M. Barnby, Vaughan Bell, Mitul A. Mehta & Michael Moutoussis. (2020) Reduction in social learning and increased policy uncertainty about harmful intent is associated with pre-existing paranoid beliefs: Evidence from modelling a modified serial dictator game. PLOS Computational Biology 16:10, pages e1008372.
Crossref
Crossref
David T Turner, Simone Burger, Filip Smit, Lucia R Valmaggia & Mark van der Gaag. (2020) What Constitutes Sufficient Evidence for Case Formulation–Driven CBT for Psychosis? Cumulative Meta-analysis of the Effect on Hallucinations and Delusions. Schizophrenia Bulletin 46:5, pages 1072-1085.
Crossref
Crossref
Andrea A. Jones, Kristina M. Gicas, Sam Seyedin, Taylor S. Willi, Olga Leonova, Fidel Vila-Rodriguez, Ric M. Procyshyn, Geoffrey N. Smith, Toby A. Schmitt, A. Talia Vertinsky, Tari Buchanan, Alex Rauscher, Donna J. Lang, G. William MacEwan, Viviane D. Lima, Julio S. G. Montaner, William J. Panenka, Alasdair M. Barr, Allen E. Thornton & William G. Honer. (2020) Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada. PLOS Medicine 17:7, pages e1003172.
Crossref
Crossref
J. M. Barnby, V. Bell, Q. Deeley & M. A. Mehta. (2020) Dopamine manipulations modulate paranoid social inferences in healthy people. Translational Psychiatry 10:1.
Crossref
Crossref
Christopher M. JonesEmily O. OlsenJulie O’DonnellDesiree Mustaquim. (2020) Resurgent Methamphetamine Use at Treatment Admission in the United States, 2008–2017. American Journal of Public Health 110:4, pages 509-516.
Crossref
Crossref
Christopher M. Jones, Natasha Underwood & Wilson M. Compton. (2019) Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17. Addiction 115:2, pages 347-353.
Crossref
Crossref
Robert A. McCutcheon, John H. Krystal & Oliver D. Howes. (2020) Dopamine and glutamate in schizophrenia: biology, symptoms and treatment. World Psychiatry 19:1, pages 15-33.
Crossref
Crossref
Qianqian Sun, Yan Zhao, Kai Zhang, Hang Su, Tianzhen Chen, Haifeng Jiang, Jiang Du, Na Zhong, Shunying Yu & Min Zhao. (2020) An association study between methamphetamine use disorder with psychosis and polymorphisms in MiRNA. Neuroscience Letters 717, pages 134725.
Crossref
Crossref
Rebecca McKetin, Olivia M. Dean, Alyna Turner, Peter J. Kelly, Brendan Quinn, Dan I. Lubman, Paul Dietze, Gregory Carter, Peter Higgs, Amanda L. Baker, Barbara Sinclair, David Reid, Victoria Manning, Nina te Pas, Wenbin Liang, Tamsin Thomas, Ramez Bathish, Margaret Kent, Dayle Raftery, Shalini Arunogiri, Frank Cordaro, Harry Hill & Michael Berk. (2019) A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence. Trials 20:1.
Crossref
Crossref
Alexandra Voce, Richard Burns, David Castle, Bianca Calabria & Rebecca McKetin. (2019) Is there a discrete negative symptom syndrome in people who use methamphetamine?. Comprehensive Psychiatry 93, pages 27-32.
Crossref
Crossref